MENLO PARK, CA
Allocation by class
Portfolio Concentration
Top 3 weight
85.1%
Top 10 weight
98.1%
Voting Authority Distribution
Total shares with voting rights: 54.31M
Full voting authority
54.31M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $452.71M 61.87% | 6.37M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $147.42M 20.15% | 25.95M | 0.00 | 0.00 |
AARDVARK THERAPEUTICS INCSOLE | COM | 3.92M | SH | $22.56M 3.08% | 3.92M | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 4.04M | SH | $21.38M 2.92% | 4.04M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 2.72M | SH | $18.86M 2.58% | 2.72M | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 464.78K | SH | $14.33M 1.96% | 464.78K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $14.23M 1.94% | 4.45M | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 52.67K | SH | $9.86M 1.35% | 52.67K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 692.05K | SH | $9.72M 1.33% | 692.05K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 3.80M | SH | $6.65M 0.91% | 3.80M | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 1.32M | SH | $6.42M 0.88% | 1.32M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 176.89K | SH | $5.99M 0.82% | 176.89K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $983.7K 0.13% | 326.81K | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 20K | SH | $625.2K 0.09% | 20K | 0.00 | 0.00 |